Dyne Therapeutics, Inc. Insider Transactions
Dyne Therapeutics, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Sell | 10,163 @ $35.33 | $359,059 | 148,792 | 06/24/2024 | 06/24/2024 | ||
Sell | 29,787 @ $35.01 | $1.04 M | 148,792 | 06/21/2024 | 06/24/2024 | ||
Sell | 26,036 @ $33.17 | $863,614 | 162,756 | 06/12/2024 | 06/13/2024 | ||
Sell | 13,964 @ $33.70 | $470,587 | 148,792 | 06/12/2024 | 06/13/2024 | ||
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 2,136 @ $31.34 | $66,942 | 147,511 | 06/11/2024 | 06/11/2024 | |
Farwell Wildon
Chief Medical Officer |
Sell | 1,628 @ $31.27 | $50,908 | 146,551 | 06/11/2024 | 06/11/2024 | |
Farwell Wildon
Chief Medical Officer |
Sell | 1,008 @ $31.27 | $31,520 | 145,543 | 06/11/2024 | 06/11/2024 | |
Sell | 2,357 @ $31.23 | $73,609 | 151,705 | 06/11/2024 | 06/11/2024 | ||
Sell | 2,913 @ $31.23 | $90,973 | 148,792 | 06/11/2024 | 06/11/2024 | ||
McNeill Jonathan
Chief Business Officer |
Sell | 1,823 @ $31.34 | $57,133 | 134,811 | 06/11/2024 | 06/11/2024 | |
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 1,331 @ $31.34 | $41,714 | 113,774 | 06/11/2024 | 06/11/2024 | |
Sell | 80,000 @ $30.24 | $2.42 M | 154,062 | 06/10/2024 | 06/11/2024 | ||
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 1,590 @ $30.23 | $48,066 | 115,105 | 06/10/2024 | 06/11/2024 | |
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 1,145 @ $34.08 | $39,022 | 149,647 | 05/20/2024 | 05/22/2024 | |
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 12,147 @ $33.51 | $407,046 | 150,792 | 05/20/2024 | 05/22/2024 | |
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 17,134 @ $32.49 | $556,684 | 162,939 | 05/20/2024 | 05/22/2024 | |
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 483 @ $28.59 | $13,809 | 149,647 | 05/16/2024 | 05/17/2024 | |
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 2,126 @ $28.20 | $59,953 | 117,157 | 05/16/2024 | 05/17/2024 | |
McNeill Jonathan
Chief Business Officer |
Sell | 2,279 @ $28.20 | $64,268 | 137,129 | 05/16/2024 | 05/17/2024 | |
Farwell Wildon
Chief Medical Officer |
Sell | 1,956 @ $28.20 | $55,159 | 148,604 | 05/16/2024 | 05/17/2024 |
Dyne Therapeutics, Inc. FAQ's
The list of insiders at Dyne Therapeutics, Inc. includes McNeill Jonathan, Brumm Joshua T, Atlas Venture Opportunity Fund I, L.P., Rhodes Jason P, Scalzo Richard William, Farwell Wildon, HIGH SUSANNA GATTI, Beskrovnaya Oxana.
Insiders have sold a total of 1.13 M Dyne Therapeutics, Inc. shares in the last 12 months for a total of 31.43 M sold.
The following insiders have sold Dyne Therapeutics, Inc. shares in the last 12 months: McNeill Jonathan ($3.87 M), Brumm Joshua T ($14.26 M), Atlas Venture Opportunity Fund I, L.P. ($1.40 M), Rhodes Jason P ($1.40 M), Scalzo Richard William ($2.55 M), Farwell Wildon ($473,404), HIGH SUSANNA GATTI ($6.22 M), Beskrovnaya Oxana ($1.26 M),